Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: gentle (98), kind (168), soft (162), weak (45)

Congenital cytomegalovirus (CMV) and hearing loss - patient information

Description: This factsheet explains what congenital cytomegalovirus (CMV) is and how it mayaffect your child's hearing.
Url: /Media/UHS-website-2019/Patientinformation/Audiology/Congenital-cytomegalovirus-CMV-and-hearing-loss-2740-PIL.pdf

Crizanlizumab Ver 1

Description: Chemotherapy Protocol Recurrent Vaso-Occlusive Crises in Sickle Cell Disease CRIZANLIZUMAB Regimen • Recurrent Vaso-Occlusive Crises in S
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sickle-Cell/Crizanlizumab-Ver-1.pdf

Buckle fracture - patient information

Description: Information about buckle fracture an injury affecting the wrist bone.
Url: /Media/UHS-website-2019/Patientinformation/Emergency-medicine/Buckle-fracture-patient-information.pdf

Azacitidine(SC)-Venetoclax

Description: Chemotherapy Protocol Acute Myeloid Leukaemia AZACITIDINE (SC) - VENETOCLAX Regimen  AML – Azacitidine (SC) - Venetoclax Indication  Newly diagnosed acute
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/AzacitidineSC-Venetoclax.pdf

Erlotinib

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ERLOTINIB Regimen NSCLC - Erlotinib Indication Second line thera
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Erlotinibver12.pdf

VenetoclaxHigh

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (high risk) Regimen • CLL – Venetoclax (high risk) I
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxHigh.pdf

After squint surgery for adults - patient information

Description: We have given you this factsheet because you have had an operation to treat a squint.
Url: /Media/UHS-website-2019/Patientinformation/Eyes/After-squint-surgery-for-adults-1781-PIL.pdf

VR-RituximabVenetoclaxCycle_1_VenetoclaxDoseTitration

Description: Chemotherapy Protocol Chronic Lymphocytic Leukaemia VR-RITUXIMAB-VENETOCLAX (high risk) Cycle 1 – Venetoclax dose titration Regim
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VR-RituximabVenetoclaxCycle-1-VenetoclaxDoseTitration.pdf

Recovering well after hysteroscopy - patient information

Description: We hope this factsheet will help to answer some of the questions you might have after having a hysteroscopy.
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Recovering-well-after-hysteroscopy-patient-information.pdf

Feasibility of covert caesarean

Description: The Court of Protection considers whether a covert caesarean section is in the best interests of a patient.
Url: /HealthProfessionals/Clinical-law-updates/Feasibility-of-covert-caesarean.aspx

141 to 150 of 380

Previous … 13 14 15 16 17 … Next